Inovio Pharmaceuticals Inc (INO): 9/8/21 Next Gen Cancer Vaccine Developme...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	3218
Boards Moderated	0
Alias Born	04/26/2007

Lakers_w

Re: None

Wednesday, 09/01/2021 2:39:21 PM

Wednesday, September 01, 2021 2:39:21 PM

9/8/21 Next Gen Cancer Vaccine Development Summit. Laurent Humeau
Chief Scientific Officer Inovio 11:15A PST. Leveraging Optimized DNA Plasmid Design and Delivery to Treat Glioblastoma Multiforme and Prostate Cancer
• Presentation of clinical trial data to show a DNA based cancer vaccine in combination with FLT3 ligand and PD-1 targeting metastatic castration resistant prostate cancer
• Updates on clinical status of a GBM vaccine in combination with cemiplimab (PD-1 inhibitor)

9/7/21 Conference Day One
Niranjan Sardesai 1:45P PST
CEO Geneos

Targeting Unique Neoantigens From Individual Patient Tumors
To Develop Novel Treatment For Cancer
• Optimized DNA plasmid containing encoded neoantigens, used in combination with IL-2 to boost T cell response
• Electroporation-based delivery system for enhanced and efficient plasmid uptake to allow optimal antigen production
• Combination therapy shows robust functional antigen specific CD4+ and CD8+ killer T cells

https://cancer-vaccine-development.com/whats-on/full-event-guide/